ALKS
Alkermes (ALKS)
NASDAQ
$41.65+$1.11 (+2.73%)
Price as of Oct 02, 2026 6:07 PM EDT
  • $6.7B
    Market Cap
  • 29.69%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 40
Valuation
ALKS
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 91
Valuation
ALKS
vs History
vs S&P 500
3-Month Momentum
-9.92%
12-Month Momentum
54.00%
3-Month Risk Adjusted Momentum
-75.88%
12-Month Risk Adjusted Momentum
138.00%

True Yield

N/A
Valuation
ALKS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.04%
Net Debt Paydown Yield
0.14%

Financial Health Score

Score: 0
Valuation
ALKS
vs History
vs S&P 500
Ohlson's O-Score
6